XmnI polymorphism frequency in heterozygote beta thalassemia subjects and its relation to Fetal hemoglobin levels

Chinelato, Isabela Sandrin; Carrocini, Gisele Cristine de Souza; Bonini-Domingos, Claudia Regina.
Rev. bras. hematol. hemoter ; 33(6): 483-483, Dec. 2011. tab
Artículo en Inglés | LILACS | ID: lil-611389

Documentos relacionados

  1. Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias.
  2. Misdiagnosis of ß-Thalassemia Major Due to Chinese <sup>G</sup>γ+(<sup>A</sup>γδß)<sup>0</sup>-Thalassemia Combined with ß<sup>0</sup>-Thalassemia.
  3. Exagamglogene Autotemcel for Transfusion-Dependent ß-Thalassemia.
  4. CRISPR/Cas9, a promising approach for the treatment of ß-thalassemia: a systematic review.
  5. Safety and efficacy of peripheral blood stem cells collection in healthy children and pediatric patients with thalassemia major weighing 20 kg or less.
  6. De novo mutation rates at the single-mutation resolution in a human <i>HBB</i> gene region associated with adaptation and genetic disease.
  7. The continuing global challenges of treating patients with beta-thalassemia.
  8. ß-Thalassemia Trait Caused by <i>SUPT5H</i> Defects: Another Case Report.
  9. Therapeutic Effects of Hematopoietic Stem Cell Derived From Gene-Edited Mice on ß654-Thalassemia.
  10. Defining curative endpoints for transfusion-dependent ß-thalassemia in the era of gene therapy and gene editing.